Preclinical Investigations of a Novel PEGylated Long-Acting Human Growth Hormone
Drug Design, Development and Therapy · 2025
DOI: 10.2147/dddt.s517485 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Jun Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Zonhon Biopharma Institute, Inc., Changzhou, Jiangsu, People's Republic of China. Hauptthemen laut MEDLINE: Human Growth Hormone, Polyethylene Glycols. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Zonhon Biopharma Institute, Inc., Changzhou, Jiangsu, People's Republic of China.
- Jiangsu Engineering Research Center for Precision Biomedicines, Changzhou, Jiangsu, People's Republic of China.
Zitieren
APA
Wang, J., Wang, H., Wang, R., Zhuang, Y., Jiang, C., Zhao, B., Xu, Z., & Ma, B. Y. (2025). Preclinical Investigations of a Novel PEGylated Long-Acting Human Growth Hormone. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s517485
Vancouver
Wang J, Wang H, Wang R, Zhuang Y, Jiang C, Zhao B, et al. Preclinical Investigations of a Novel PEGylated Long-Acting Human Growth Hormone. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s517485
BibTeX
@article{Wang2025,
author = {Wang, Jun and Wang, He and Wang, Rong and Zhuang, Yu and Jiang, Chenyang and Zhao, Baixue and Xu, Zhen and Ma, Bruce Yong},
title = {Preclinical Investigations of a Novel PEGylated Long-Acting Human Growth Hormone},
journal = {Drug Design, Development and Therapy},
year = {2025},
doi = {10.2147/dddt.s517485}
}
EUVIMED